DSIP vs Lanreotide
Overview
DSIP is primarily a sleep & recovery peptide, while Lanreotide is used for hormonal.
This page compares DSIP and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| DSIP | Lanreotide | |
|---|---|---|
| Category | Sleep & Recovery | Hormonal |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 100-300 mcg | 60-120 mg |
| Frequency | before bed | every 4 weeks |
| Reported benefits | Improved deep sleep, stress reduction, recovery enhancement, pain reduction | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Very well-tolerated, possible grogginess | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. DSIP is categorised under Sleep & Recovery, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. DSIP: not FDA-approved; compounding permitted with a prescription as of April 2026. Lanreotide: FDA-approved.
Dosing. DSIP is typically dosed at 100-300 mcg (before bed). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking DSIP and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between DSIP and Lanreotide?
- DSIP is primarily a sleep & recovery peptide, while Lanreotide is used for hormonal. DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Lanreotide is FDA-approved for one or more indications.
- What is DSIP used for?
- Delta sleep-inducing peptide.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take DSIP and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking DSIP and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is DSIP or Lanreotide FDA-approved?
- DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026). Lanreotide is FDA-approved for one or more indications.
Read the full articles
- DSIP — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references